Finnrick - Ensuring a Safer and More Transparent Supply Chain
Changsha Xjun Technology

Changsha Xjun Technology

Retatrutide

Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Changsha Xjun Technology between 31 Aug 2025 and 3 Mar 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).

Finnrick Rating™
Changsha Xjun Technology
Retatrutide
Tested 6 Samples
Last test 3 Mar 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Retatrutide tests from top-rated vendors:

All Retatrutide tests from Changsha Xjun Technology

Samples are tested in commercial labs

Tests Count

6

Scores

AVG6.5MIN2.5MAX8.0

Last

3 Mar 2026

First

31 Aug 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
3 Mar 2026View8.030mg29.7mg-1.0%99.90%(no batch ID)No Label / Silver Crimp / White CapLab EPublic
22 Feb 2026View2.510mg12.4mg+24.0%98.51%(no batch ID)No Label / Silver Crimp / Yellow CapLab EPublic
22 Feb 2026View4.710mg12mg+20.0%99.79%(no batch ID)No Label / Silver Crimp / Yellow CapLab EPublic
22 Feb 2026View8.030mg30.8mg+2.7%99.90%(no batch ID)No Label / Silver Crimp / White CapLab EPublic
22 Feb 2026View8.030mg31.1mg+3.7%99.90%(no batch ID)No Label / Silver Crimp / White CapLab EPublic
31 Aug 2025View7.920mg17.5mg-12.5%99.89%2025070501White Label / Silver Crimp / Violet CapLab EPublic